Rhumbline Advisers Vir Biotechnology, Inc. Transaction History

Rhumbline Advisers

$113 Billion
Q2 2025

A detailed history of Rhumbline Advisers transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 228,949 shares of VIR stock, worth $1.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

228,949

Previous 226,649 1.01%

Holding current value

$1.3 Million

Previous $1.47 Million 21.46%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 12, 2025	BUY	$4.5 - $6.48 $10,350 - $14,904	2,300 Added 1.01%	228,949 $1.15 Million
Q1 2025 Apr 08, 2025	SELL	$6.48 - $12.48 $65,007 - $125,199	-10,032 Reduced 4.24%	226,649 $1.52 Million
Q4 2024 May 29, 2025	BUY	$6.74 - $10.17 $67,615 - $102,025	10,032 Added 4.43%	236,681 $1.74 Million
Q4 2024 Jan 30, 2025	BUY	$6.74 - $10.17 $8,681 - $13,098	1,288 Added 0.55%	236,681 $1.74 Million
Q3 2024 Nov 12, 2024	SELL	$7.26 - $10.7 $22,585 - $33,287	-3,111 Reduced 1.3%	235,393 $1.76 Million
Q2 2024 Aug 01, 2024	BUY	$7.63 - $12.66 $74,903 - $124,283	9,817 Added 4.29%	238,504 $2.12 Million
Q1 2024 May 09, 2024	SELL	$8.6 - $11.9 $402,230 - $556,574	-46,771 Reduced 16.98%	228,687 $2.32 Million
Q4 2023 Feb 08, 2024	BUY	$7.76 - $10.29 $104,534 - $138,616	13,471 Added 5.14%	275,458 $2.77 Million
Q3 2023 Nov 09, 2023	BUY	$9.14 - $24.62 $131,378 - $353,887	14,374 Added 5.81%	261,987 $2.45 Million
Q2 2023 Aug 08, 2023	BUY	$23.2 - $27.29 $283,620 - $333,620	12,225 Added 5.19%	247,613 $6.07 Million
Q1 2023 May 11, 2023	BUY	$22.26 - $30.85 $326,465 - $452,446	14,666 Added 6.64%	235,388 $5.48 Million
Q4 2022 Feb 14, 2023	SELL	$19.96 - $28.22 $32,834 - $46,421	-1,645 Reduced 0.74%	220,722 $5.59 Million
Q3 2022 Nov 10, 2022	BUY	$18.26 - $31.1 $138,063 - $235,147	7,561 Added 3.52%	222,367 $4.29 Million
Q2 2022 Aug 11, 2022	BUY	$19.08 - $26.7 $2.86 Million - $4.01 Million	150,037 Added 231.65%	214,806 $5.47 Million
Q1 2022 May 12, 2022	BUY	$21.19 - $40.01 $19,388 - $36,609	915 Added 1.43%	64,769 $1.67 Million
Q4 2021 Feb 10, 2022	SELL	$30.97 - $54.03 $14,865 - $25,934	-480 Reduced 0.75%	63,854 $2.67 Million
Q3 2021 Nov 12, 2021	BUY	$34.9 - $54.54 $48,266 - $75,428	1,383 Added 2.2%	64,334 $2.8 Million
Q2 2021 Aug 05, 2021	BUY	$38.75 - $51.0 $99,432 - $130,866	2,566 Added 4.25%	62,951 $2.98 Million
Q1 2021 May 06, 2021	SELL	$26.34 - $83.07 $133,017 - $419,503	-5,050 Reduced 7.72%	60,385 $3.1 Million
Q4 2020 Feb 10, 2021	BUY	$25.51 - $43.38 $109,871 - $186,837	4,307 Added 7.05%	65,435 $1.75 Million
Q3 2020 Nov 12, 2020	SELL	$28.28 - $53.6 $217,162 - $411,594	-7,679 Reduced 11.16%	61,128 $2.1 Million
Q2 2020 Aug 13, 2020	BUY	$27.89 - $47.86 $1.62 Million - $2.79 Million	58,253 Added 551.95%	68,807 $2.82 Million
Q1 2020 May 06, 2020	BUY	$12.04 - $60.2 $127,070 - $635,350	10,554 New	10,554 $362,000

Others Institutions Holding VIR

# of Institutions

242

Shares Held

109M

Call Options Held

342K

Put Options Held

150K

View Full List

About Vir Biotechnology, Inc.

Ticker VIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 132,638,000
Market Cap $751M
Description
Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...

More about VIR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Account

Rhumbline Advisers Vir Biotechnology, Inc. Transaction History